Clinical Trial Update: Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the combination of cryosurgery and NK immunotherapy for metastatic esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Metastatic Esophageal Cancer | Phase 1, Phase 2 | Status: COMPLETED